Quick answer

CEA monitors colorectal-cancer treatment response and recurrence — established-diagnosis territory where it performs well. As a screening tool for healthy people, smoking and benign conditions elevate it enough to render single readings meaningless.

Appropriate versus inappropriate uses

Use caseValidity
Post-colorectal-cancer-surgery surveillance (q3mo ×2yr)established standard — rising CEAs precede imaging-visible recurrences
Metastatic-disease treatment-response trackingvaluable adjunct
Symptomatic-patient workup contributionsupportive role alongside colonoscopy/imaging
Healthy-person cancer SCREENINGinvalid — colonoscopy/FIT own that job
Smoker's elevated reading interpreted alonemeaningless — tobacco raises CEA independently

The screening hierarchy reminder

Colorectal-cancer prevention runs through COLONOSCOPY (lesion REMOVAL, not just detection) and FIT-stool testing — tumor markers participate nowhere in prevention. Someone avoiding colonoscopy by ordering CEA bloodwork substitutes false comfort for genuine protection.

Other CRA-elevating conditions

Smoking (major), IBD, pancreatitis, liver disease, hypothyroidism, other GI malignancies (gastric/pancreatic), and advanced-age benign drifts. Half-measures like 'slightly elevated CEA' in smokers generate cascades ending nowhere — clinical context weighs heavily before invasive responses.

Surveillance protocol snapshot

Stage-II/III colorectal post-resection: CEA every 3-6 months ×2 years then 6-monthly ×3-5 years, with periodic CT-chest/abdomen/pelvis and colonoscopy scheduling — CEA upticks trigger imaging hunts catching resectable recurrences earlier.

Frequently asked questions

Can CEA replace colonoscopy screening?

Emphatically no — colonoscopy PREVENTS cancers via polypectomy; CEA merely observes existing disease behavior.

Normal CEA clears my colorectal-cancer worry?

Opposite failure mode: CEA-negative primaries occur ~30-40% of the time — colonoscopy criteria ignore CEA entirely.